Related Experiment Videos

Clinical aspects of cardiovascular effects of H2-receptor antagonists

H Hinrichsen¹, A Halabi, W Kirch

¹Medical Department, Christian-Albrechts-University, Kiel, Germany.

European Journal of Clinical Investigation

|March 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.

Journal of viral hepatitis·2017

Influence of Carbimazole on Serum Levels and Haemodynamic Effects of Digoxin.

Clinical drug investigation·2016

Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver Disease.

Clinical drug investigation·2016

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease.

British journal of clinical pharmacology·2015

Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: favorable impact of dose up-titration.

Journal of clinical pharmacology·2014

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment.

Diabetes, obesity & metabolism·2013

See all related articles